Evidence map›Paper›PMID 33859549›Full record

ReviewFrontiers in neuroscience2021

Impact of the Olig Family on Neurodevelopmental Disorders.

Jenny Szu, Alexandre Wojcinski, Peng Jiang, Santosh Kesari

Abstract readReview
In one paragraph

Review in Frontiers in neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. The Therapeutic Potential of Purmorphamine Across Disease Models.Journal of cellular and molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Rat Glioma 101.8 Tissue Strain: Molecular and Morphological Features.International journal of molecular sciences · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Evolution and development of extraocular motor neurons, nerves and muscles in vertebrates.Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jenny SzuDepartment of Translational Neurosciences and Neurotherapeutics, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, United States.
Alexandre WojcinskiDepartment of Translational Neurosciences and Neurotherapeutics, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, United States.
Peng JiangDepartment of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, United States.
Santosh KesariDepartment of Translational Neurosciences and Neurotherapeutics, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, United States.

Funding

Understanding Down Syndrome Brain Development Using Human iPSC-Based Mouse ChimerasR01NS122108 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI Peng Jiang · 2021 to 2026
$2.1M
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and DiseaseR01NS102382 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI JIANG, PENG · 2018 to 2022
$1.6M
NINDS NIH HHS R01 NS102382NINDS NIH HHS R01 NS122108
6 · The paper itself

Abstract

The

Indexed as

autism spectrum disorderdown syndromeneurodevelopmentOligtranscription factor

Identifiers

PMID33859549
PMCPMC8042229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.